Expects U.S. XPOVIO net product revenue to be approximately $25M for the fourth quarter 2023 and approximately $112M for the full year 2023, meeting company’s guidance. Cash, cash equivalents, restricted cash and investments as of December 31, 2023 was approximately $192M, enabling an expected cash runway into late 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>